A detailed history of Crossmark Global Holdings, Inc. transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 7,828 shares of MEDP stock, worth $2.68 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
7,828
Previous 6,035 29.71%
Holding current value
$2.68 Million
Previous $2.49 Million 5.15%
% of portfolio
0.05%
Previous 0.05%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$320.58 - $457.29 $574,799 - $819,920
1,793 Added 29.71%
7,828 $2.61 Million
Q2 2024

Jul 29, 2024

SELL
$372.0 - $424.34 $53,196 - $60,680
-143 Reduced 2.31%
6,035 $2.49 Million
Q1 2024

May 13, 2024

SELL
$284.87 - $413.31 $69,793 - $101,260
-245 Reduced 3.81%
6,178 $2.5 Million
Q4 2023

Feb 13, 2024

SELL
$227.52 - $312.68 $27,984 - $38,459
-123 Reduced 1.88%
6,423 $1.97 Million
Q3 2023

Nov 08, 2023

BUY
$233.98 - $281.67 $616,303 - $741,918
2,634 Added 67.33%
6,546 $1.61 Million
Q2 2023

Jul 31, 2023

BUY
$187.26 - $240.17 $3,183 - $4,082
17 Added 0.44%
3,912 $997,000
Q1 2023

May 12, 2023

BUY
$174.31 - $239.52 $16,036 - $22,035
92 Added 2.42%
3,895 $733,000
Q4 2022

Jan 19, 2023

SELL
$153.06 - $226.57 $208,467 - $308,588
-1,362 Reduced 26.37%
3,803 $807,000
Q3 2022

Nov 01, 2022

SELL
$145.13 - $182.49 $45,861 - $57,666
-316 Reduced 5.77%
5,165 $812,000
Q2 2022

Jul 29, 2022

SELL
$130.2 - $168.03 $48,043 - $62,003
-369 Reduced 6.31%
5,481 $820,000
Q1 2022

May 11, 2022

BUY
$138.87 - $214.31 $447,161 - $690,078
3,220 Added 122.43%
5,850 $957,000
Q4 2021

Jan 10, 2022

SELL
$182.74 - $227.9 $575,631 - $717,885
-3,150 Reduced 54.5%
2,630 $572,000
Q3 2021

Oct 21, 2021

BUY
$170.18 - $198.21 $983,640 - $1.15 Million
5,780 New
5,780 $1.09 Million
Q3 2021

Oct 13, 2021

SELL
$170.18 - $198.21 $1.04 Million - $1.22 Million
-6,130 Closed
0 $0
Q2 2021

Jul 21, 2021

SELL
$158.62 - $194.3 $41,241 - $50,518
-260 Reduced 4.07%
6,130 $1.08 Million
Q1 2021

Apr 15, 2021

BUY
$132.02 - $168.26 $6,601 - $8,413
50 Added 0.79%
6,390 $1.05 Million
Q4 2020

Jan 14, 2021

BUY
$109.38 - $149.19 $64,534 - $88,022
590 Added 10.26%
6,340 $883,000
Q3 2020

Oct 08, 2020

SELL
$92.95 - $130.61 $19,519 - $27,428
-210 Reduced 3.52%
5,750 $643,000
Q2 2020

Aug 14, 2020

BUY
$68.08 - $95.68 $18,381 - $25,833
270 Added 4.75%
5,960 $554,000
Q1 2020

Apr 28, 2020

SELL
$61.71 - $101.95 $3,085 - $5,097
-50 Reduced 0.87%
5,690 $417,000
Q4 2019

Feb 06, 2020

SELL
$70.08 - $84.64 $167,491 - $202,289
-2,390 Reduced 29.4%
5,740 $483,000
Q3 2019

Oct 09, 2019

SELL
$62.38 - $85.89 $8,109 - $11,165
-130 Reduced 1.57%
8,130 $683,000
Q2 2019

Jul 09, 2019

SELL
$53.64 - $65.42 $43,448 - $52,990
-810 Reduced 8.93%
8,260 $540,000
Q1 2019

May 02, 2019

BUY
$49.38 - $70.58 $447,876 - $640,160
9,070 New
9,070 $535,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.7B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Crossmark Global Holdings, Inc. Portfolio

Follow Crossmark Global Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.